Site map
An overview of the available content on this site. Keep the pointer still over an item for a few seconds to get its description.
- Membership
- Governance
-
Our Team
- Michael Youdell
- Sandie Wellman
- Jackie Parker
- Graham Collins
- Sophie De Gouveia
- Emily Annear
- Kea Hinsley
- Toby Eyre
- David Cutter
- Gareth Turner
- Mariolina Salio
- Anna Schuh
- Brian Nicholson
- Shivan Sivakumar
- Rachael Bashford-Rogers
- Enas Abu-Shah
- Mark Middleton
- Penny Clark
- Somnath Mukherjee
- Eric O'Neill
- Michael Dustin
- Constantin Coussios
- Siim Pauklin
- Kate Lines
- Raj Thakker
- John Todd
- Emma Culver
- Gillian Farnie
- David Kerr
- James East
- Francesco Boccalleto
- Rachel Kerr
- Francesco Pezzella
- David Church
- Eileen Parkes
- Alistair Easton
- Jan Bornschein
- Shijie Cai
- Nick La Thangue
- Walter Bodmer
- Tim Maughan
- Pratik Samant
- Frank Van Den Heuvel
- Anna Vella
- Alastair Gray
- Paolo Candio
- Joshua Hordern
- Xin Lu
- Nicola Ternette
- Benedikt Kessler
- Richard Colling
- Naomi Allen
- Tim Key
- Francesca Buffa
- Chris Holmes
- Clare Verrill
- Jens Rittscher
- Simon Leedham
- Fergus Gleeson
- Mike Brady
- Jim Davies
- Michael Parker
- Stefan Neubauer
- Charalambos Antoniades
- Martin Landray
- Alison Noble
- Anna Schuh
- Helene Dreau
- Dimitrios V. Vavoulis
- Katie Ridout
- Laura Lopez
- Anthony Cutts
- Daniella DiSalvo Williams
- Flavia Matos Santo
- Niamh Appleby
- Adam Burns
- Daisy Jennings
- Sarah Blagden
- Graham Collins
- Shibani Nicum
- Mark Middleton
- Shivan Sivakumar
- Eileen Parkes
- Adam Mead
- Paresh Vyas
- Anna Schuh
- Karthik Ramasamy
- Tim Maughan
- Simon Lord
- Alistair Easton
- Geoff Higgins
- David Church
- Rui Ma
- Leticia Campo
- Molly Browne
- Simon Buczacki
- Gillian Reeves
- Laura Spiers
- Mark Middleton
- Tim Elliott
- Daniel McGowan
- Ruth McPherson
- Jane Holmes
- Cathy Qi
- Benjamin Schuster-Böckler
- Heather Harrington
- Helen Byrne
- Feng Wu
- Michael Gray
- Paul Lyon
- Noor Bekkali
- Shaun Scott
- test test
- Benoît Van den Eynde
- Carol Leung
- Adrian Hill
- Irina Redchenko
- Sarah Blagden
- Eva Morris
- Julia Hippisley-Cox
- Philip Maini
- Chris Pugh
- Ulrike Tillmann
- Mark Coles
- Eamonn Gaffney
- Hashem Koohy
- Daniel Royston
- Barbara Braden
- Nick Maynard
- Alison Noble
- Ian Mills
- Victoria Woodcock
- Richard Bryant
- Alastair Lamb
- Freddie Hamdy
- Ronjon Chakreverty
- Kim Midwood
- Ben Fairfax
- Audrey Gérard
- Fiona Powrie
- Holm Uhlig
- Robert Carlisle
- Andrew McMichael
- Ricardo Fernandes
- Oliver Brain
- Paul Klenerman
- Persephone Borrow
- Ahmed Ahmed
- Kate Vallis
- Puneet Plaha
- Martina McAteer
- Hagan Bayley
- Udo Oppermann
- Chris Schofield
- Daniel Anthony
- Nicola Sibson
- Richard Hobbs
- David Hunter
- Jenny Taylor
- Amato Giaccia
- Eleanor Stride
- Chas Bountra
- Constantinos Koshiaris
- Kassim Javaid
- Ellie Barnes
- David Hunter
- Gil McVean
- Gagandeep Batth
- Georgeta Ciuban
- Arman Ardalan
- Françoise Howe
- Julliet Lwiindi
- Jackie Fellows
- Elizabeth Mann
- Daniel McAleese
- Geraldine Gillespie
- Sir Andrew McMichael
- Sarah Rowland-Jones
- Susannah Cronin
- Audrey Gérard
- Catriona Gilmour Hamilton
- Sara Danielli
- Chen-Chun Pai
- Elizabeth Smyth
- Richard Owen
- Sheraz Markar
- Bethan Psaila
- Daniel Woodcock
- Tao Dong
- Ignacio Melero
- Omer Dushek
- Len Seymour
- Alison Simmons
- Guanke Bao
- Waseem Qureshi
- Andrew Blake
- Sharon Tonner
- Ly Mee Yu
- Sarah Pearson
- Tamsin Cargill
- Michael Pavlides
- Alex Gordon-Weeks
- Jane McKeating
- Felipe Galvez-Cancino
- Kerry Fisher
- Catherine Green
- Kate Ridout
- Pauline Robbe
- Grigore-Aristide Gafencu
- Silvia Halim
- Melinda Kormany
- Thomas Wenban-Smith
- Joshua Abbott
- Ismail Draguma
- David Maxen
- Simon Buczacki
- Isabela Pedroza-Pacheco
- Rosalin Cooper
- Agata Reclaw
- Eleni Adamopoulou
- Luciana Gneo
- Qian Yang
- Helen White
- Anindita Roy
- Jack Bartram
- Anna Prazmo
- Sarah Inglott
- Contact Us
- Projects
-
Networks & Consortia
- Oxford Lymphoid Disorders Study Group
- PancrImmune
- Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre
- S:CORT
- ACRCelerate
- ART-NET
- EHNBPCCG
- European Prospective Investigation into Cancer and Nutrition (EPIC)
- Southampton Immune Accelerator
- National Consortium for Intelligent Medical Imaging (NCIMI)
- Networks & Consortia
- PathLAKE
- National Cancer Imaging Translational Accelerator (NCITA)
- Oesophagogastric Cancer Centre of Excellence
- Liver Cancer Centre of Excellence
- Oxford Cancer Vaccine Hub
- Themes
-
Exemplars
- Making digi-trials a reality for cancer
- Using online platforms to empower patient driven research
- New statistical tools for the topological data analysis of tumour tissue
- In silico simulation of the tumour-host interaction
- Applying morpho-molecular pathology
- Optimising cancer detection and diagnosis in primary care
- The Million Women Study
- Application of topological data analysis to clinical trials
- Developing intelligent image-based predictors of GI & lung cancer risk
- Understanding prostate cancer progression
- Remodelling the tissue immune microenvironment (TIME) during tumour development
- Optimising TIME for radiotherapy response
- Comprehensive characterisation of shared immune mechanisms in organ-specific checkpoint induced and spontaneous autoinflammation
- Determining the molecular basis for the relationship between IT efficacy and toxicity
- Reducing systemic dose whilst enhancing efficacy
- Identification of cancer epitope targets
- Determination of the relative importance of T-cell intrinsic and extrinsic factors in immune escape
- Activation of tumour infiltrating B cells
- Assessing risk of cancer using GP patient records
- Factors determining ovarian cancer risk
- Integrating molecular diagnostics to predict progression from monoclonal gammopathy of undetermined significance (MGUS) to myeloma and intercept & treat individuals at highest risk
- Universal consent at the Oxford University Hospitals (OUH) Translational Gastroenterology Unit
- Early intervention trials
- Development of multi-cancer tests and studying early cancer biology
- Choosing the right diagnostic test to improve the patient experience
- Polygenic risk scores
- Oxford CRUK Clinical Trials Unit Collaboration
- LynchVax
-
Funding Support
- CRUK Oxford Centre Development Fund
- Human Immune Discovery Initiative
- UKRI Funding Opportunities
- CRUK Funding Opportunities
- Medical Science Division Funding Directory
- Other Funding Opportunities
- Medical and Life Sciences Translational Fund
- The University Challenge Seed Fund
- Departmental PER Seed Fund
- The Oxford Seed Fund (OSF)
- Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme
- Oxford Centre for Early Cancer Detection (OxCODE) Funding Scheme
-
Translational Histopathology Lab
- Tissue Processing, Embedding and Sectioning
- Haematoxylin & Eosin (H&E) Staining
- Antibody Optimisation
- Single and Double Antibody Tissue Staining (Chromogenic IHC)
- Slide Scanning, Automated Tissue Segmentation and Scoring
- TMA Construction
- Multi-plex Immunofluorescence (IF) and Imaging
- HALO® – Image Analysis Platform
- Frequently Asked Questions
- Oxford Molecular Diagnostics Centre
- Patient Sample Access
- Clinical Trial Support
- Clinical Positioning Network
- Patient & Public Involvement (PPI) Panel
- Communication & Press Support
- Patient & Public Involvement (PPI)
- Patient and public involvement (for researchers)
- Conversations about cancer vaccines
- Alumni Destinations
- Prospective DPhil Student Mailing List
-
Students
- Alba Rodriguez-Meira
- Bobby White
- Jan Brauner
- Chee Kin Then
- George Atkinson
- Cornelius Emde
- Guilia Celora
- Michael Selby
- Felix Jackson
- Rhydian Windsor
- Natalia Garcia Martin
- Siu Shing Wong
- Khoa Chung
- Mark Brooke
- James Coates
- Sarah Faulkner
- Wenjun Huang
- Jessica Whitburn
- Ashvina Segaran
- Nina Wietek
- Ben Harris
- Karen Sayal
- Tamsyn Clark
- Katherine English
- Rory Peters
- Jonathan Kwok
- Helen Tyrell
- Max van Essen
- Ruichong Ma
- Serena Lucotti
- Johanna Ramroth
- Andrew Dhawan
- Kezia Gaitskell
- Lucy Denly
- Hannah Fuchs
- Tara Seedher
- Giampiero Valenzano
- Lena Duma
- Holly Eggington
- Hannah Baillie
- Hannah Pook
- David Maxen
- Roy Rosman Nathanson
- Aglaia Skolariki
- Heather Clark
- Matthew Dean
- James Bundred
- New hydrogel technology has promise in breast cancer modelling
- Understanding breast cancer risk in Chinese populations
- Study sheds light on risks of breast cancer after pre-invasive disease
- Using big data in breast cancer research
- Funding boost for OxPLoreD early detection study
- A new FRONTIER for breast cancer
- $410 million buy out for Oxford cancer detection technology
- Innovative drug delivery techniques show promise in clinical trials
- Detecting pancreatic cancer through blood tests
- The search for pancreatic cancer biomarkers
- Oxfordshire-based SCAN pathway wins BMJ award
- Understanding breast cancer management in women of different ethnicities
- Prof. Ellie Barnes comments on the 2020 Nobel Prize for Medicine
- How chemotherapy impacts the body
- New AI technology to help research into cancer metastasis
- Therapeutic potential for breast cancer found in the matrix
- First Huaxi SCU-Oxford Forum on Gastrointestinal Cancer
- Understanding the developmental origins of resistant infant leukaemia
- Understanding clonal haematopoiesis for COVID and cancer
- Helping blood cancer patients in the COVID era
- Tackling blood cancers in Tanzania and Uganda
- Previously unknown ‘genetic vulnerability’ in breast cancer found
- Balancing the benefits and risks of radiotherapy for Hodgkin lymphoma
- Epigenetic markers for melanoma patient response to ICB therapy
- Harnessing immune cell therapy in cancer
- Early stage ‘red flag’ symptoms for pancreatic cancer
- Oxford Cancer alumni’s biotech success
- What we can learn from cancer survivors
- New melanoma cancer drug in development shows promise
- The relationship between iRhom2 and KRAS proteins
- The impact of COVID-19 on cancer patients
- IL-22 pathway linked to poor prognosis in colon cancer
- Oxford lymphoid study group established
- The relationship between unexpected weight loss & cancer
- TP53 gene determines severe blood cancer development
- Using DNA & RNA to treat cancers
- SCALOP team discover new pancreatic cancer biomarker
- Researchers discover cell communication mechanism that drives cancer adaptation
- Prof Anna Schuh wins Vice-Chancellor Innovation Award
- Using machine-learning approaches to identify blood cancer types
- Researchers discover mutation that determines treatment efficiency
- New digital classification method using AI developed for colorectal cancer
- Mapping the T-cell landscape of pancreatic cancer
- QResearch researchers collaborate on two major cancer projects
- Oxford to lead new programme of AI research to improve lung cancer screening
- Yang Shi joins the Oxford Cancer community
- New melanoma drug a step closer to the clinic
- Using AI to improve the quality of endoscopy videos
- Potential of DNA-based blood tests for detecting pancreatic cancer earlier
- Investigating the effects of co-morbidities on liver cancer risk
- Being a part of cancer drug discoveries
- Oxford spin out financed $6.8m for research into oncolytic therapies
- “The Oxford Classic” classification system uncovers new information about ovarian cancers
- Bowel cancer patients going undiagnosed due to COVID distruption
- New form of gift wrap drives male reproductive success
- New sequencing methods for distinguishing DNA modifications
- Oxford Cancer Centre appoints Prof. Tim Elliot as new co-director
- Following the cancer metabolomic breadcrumb trail
- New Oxford spin-out Singula Bio launches
- Detecting myeloma earlier
- Detecting for multiple cancers in one simple test
- Studying viral genetics to aid liver cancer early detection
- Understanding how cancer arises from infected tissue
- Christina Ye awarded CRUK pre-doctoral fellowship
- Finding extracellular vesicle biomarkers for oesophageal cancer early detection
- Understanding how inherited and acquired mutations interact to affect cancer
- New Oxford technology assesses cancer patient vulnerability to COVID-19
- Developing a system to simultaneously detect genetic and epigenetic information
- Power of the patient voice
- Virtual Annual Cancer Symposium 2020
- Affordable approaches to earlier cancer diagnosis in India
- Drug target potential for myelofibrosis
- New start-up Base Genomics launches
- Oxford joins cancer coronavirus registry project
- Oxford technology holds great promise for a multi-cancer blood test
- Oxford University and Sichuan University form joint Centre for Gastrointestinal Cancer
- Dr Eileen Parkes joins Oxford cancer community
- Professor Sir Peter Ratcliffe elected as an AACR Academy Fellow
- Tackling oesophageal cancer early detection challenges through AI
- Oesophageal Cancer Focus Month: DPhil Spotlight – Pek Kei Im (Becky)
- Drinking alcohol regularly increases cancer risk in Chinese populations
- Improving immunotherapy through epigenetics
- Registration open for Cancer Early Detection and Epigenetics Symposium
- Prof Andi Roy receives new award for immune-cell research
- DeLIVER clinical research study underway as recruitment opens
- New partnership enables access to state-of-the-art radiotherapy machine
- Novel imaging device enters first round of development funding programme
- Funding to improve childhood, teenage and young adult cancer detection
- Oxford spin out influencing patient care world wide
- New funding for early diagnosis research using platelets
- Early Detection Award for research into the clinical application of single cell genomics
- Higher testosterone levels in men linked to greater melanoma risk
- Prioritising COVID-19 research questions for the cancer population
- Oxford at the American Association for Cancer Research Annual Meeting
- New clinical prediction tools for myeloma
- T-cell landscape mapping identifies new targets for pancreatic cancer immunotherapy
- Artwork donated to Oxford ward for patients undergoing cancer clinical trials
- Further funding secured to hunt out cancer using innovative radiotherapy techniques
- Oxford success at the early detection sandpit on pancreatic cancer
- State-of-the-art robots to improve Oxford cancer care
- Using Herpesvirus to fight cancer
- New method for cost-effective genome-wide DNA methylation analysis
- Understanding mutation progression to detect ovarian cancer earlier
- First patient dosed with drug designed to re-sensitise patients to cancer treatment
- Adrian Hill elected to Royal Society
- New study investigates how growth factors in our gut could initiate cancer
- New prostate cancer risk tool developed
- Professor David Hunter honoured by the Academy of Medical Sciences
- Study reveals how cancer cells use bone marrow fat for growth and survival
- Artificial intelligence tool for streamlining pathology workflow
- Cancer immunologist Lieping Chen joins Ludwig Oxford as a Visiting Professor
- Eoghan Mulholland awarded colorectal cancer fellowship
- AI endoscopy project enables 3D surface measurements of Barrett's oesophagus
- The nervous system & cancer progression
- Groundbreaking FOCUS4 clinical trials report their findings at ASCO
- Reduced antibody response to COVID vaccination in myeloid blood cancers patients
- Early diagnosis of lymphoma in children and young adults in sub-Saharan Africa
- Two clinical academic research partnerships awarded to Oxford researchers
- Potential for radiotherapy and VTP multimodality therapy for prostate cancer
- 14 new CRUK Oxford Centre Development Fund Awardees
- Study investigating targeted drug delivery by focused ultrasound for pancreatic cancer opens
- Oxford Cancer welcomes Professor Stefan Constantinescu
- The next step in personalised cancer medicine
- New network Oxford Cancer launches
- Mechanism behind repair of cancer-inducing mutations discovered
- Protein structure solution paves way for improved anti-cancer drugs
- Oxford wins government funding to evaluate prostate cancer detection system
- AI software to help clinicians diagnose lung cancer earlier and reduce patient waiting lists
- Oxford Cancer – behind the brand
- NCITA Publishes Comment Article in the British Journal of Cancer
- Oxford spin out partners with J&J to transform lung cancer treatment
- World Chronic Lymphoid Leukaemia Day 2021
- Two Oxford immunotherapy research projects awarded funding by Prostate Cancer UK
- Vaccine for treating cancer made possible using Oxford COVID vaccine technology
- Oxford’s cancer-risk research featured in special edition of PLOS Medicine focussed on advances in early cancer detection
- Oxford Cancer Analytics awarded £1.27M to revolutonise lung cancer management
- Oxford to assess revolutionary multi-cancer blood test in trial, for future implementation in the NHS
- New drug shows promise in slowing growth of bowel cancer
- FOCUS4: a flagship trial in colorectal cancer
- Turing Fellowships for Oxford cancer researchers
- New atlas revealed of bone marrow haematopoiesis during development
- Changes in blood cell production over the human lifetime may hold clues to patterns of disease
- Changing drinking patterns in China could drive a major increase in liver diseases
- Anti-cancer drug derived from fungus shows promise in clinical trials
- Blood tests may predict response to immunotherapy for melanoma
- Haematology workshops enable significant patient involvement
- Oxford cancer clinical trials unit receives acclaimed nursing award
- Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme
- Applied mathematical principles help identify immune cell spatial patterns in tumours
- Pancreatic cancer early detection funds awarded to Oxford researchers
- Oxford ranked first in the world for Computer Science
- Advancing radiotherapy technology through clinical trials
- Impact award for publication on ovarian cancer
- Identifying early clinical features of myeloma in primary care
- New symptoms identified to help doctors diagnose pancreatic cancer
- Fewer cases of children’s cancer picked up during COVID pandemic
- Datasets used to train AI to detect skin cancer lack information on darker skin and often incomplete
- Vaccinated patients who are immunosuppressed from chemotherapy identified as highest risk for hospitalisation and death
- World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition
- Study reveals ‘stop-eating’ response to DNA damage
- New study confirms an infectious bacterium is a major cause of stomach cancer in China
- MP Anneliese Dodds tours Oxford cancer research
- New model for infant leukaemia announced
- Strong immune responses in myeloma patients after two doses of COVID vaccine
- New healthcare partnership for Oxfordshire cancer research spin-out
- Tamsyn Clark awarded Raven prize by British Association of Surgical Oncology
- Dr Heba Sailem wins international award for work on cancer gene functions
- Increasing the durability of immunotherapy
- Medical imaging 'flight simulator' spun out as new company & training tool
- Alba Rodriguez-Meira to give plenary lecture at the annual American Society of Hematology (ASH) Meeting and Exposition
- New study highlights importance of early diagnosis for ovarian cancer survival
- New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread
- Eileen Parkes awarded Wellcome Clinical Research Career Development Fellowship
- First patient dosed with lung cancer immunotherapy vaccine
- Groundbreaking Oxford research could lead to early diagnosis of pancreatic cancer
- Cancer Research UK to invest £11 million into cancer science in Oxford
- New genetic study confirms that alcohol is a direct cause of cancer
- Reprogramming tumour cells using an antimalarial drug
- How Oxford has shaped cancer science
- Identifying protein biomarkers for pancreatic cancer
- New study shows MRI-guided radiotherapy could double survival rates for people with inoperable pancreatic cancer
- Toral Gathani awarded Professorship for work into ethnicity and breast cancer
- New study finds aromatase inhibitors better at reducing chances of breast cancer recurrence
- 12 new Development Fund awardees
- TAPS for cancer detection
- DNA link could unlock mystery of cancer patients ‘wasting away’
- First major UK prospective study for liver cancer underway
- New study finds lower risks of cancer for vegetarians, pescatarians and low meat-eaters
- UK-first cancer operation in Oxford
- Adiposity in early life, but not adulthood, may protect against breast cancer
- Blood tests provide no additional information to FIT alone when prioritising patients for colorectal cancer referral
- Oxford researchers at AACR 2022
- Funding to develop a new device for breast cancer detection
- Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
- Automated assessment of pathology image quality
- Predicting early recurrence of pancreatic cancer
- Greater adiposity linked to increased risk of fatal prostate cancer
- Dairy products linked to increased risk of cancer
- Genetic testing could reduce adverse effects and hospital costs of a widely used chemotherapy
- Early detection innovation award for Oxford researchers
- Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
- National clinical study launched to test new technologies for detecting liver cancer
- Largest study to date confirms role of two hormones in aggressive prostate cancer risk
- Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis
- Oxford Cancer researchers elected to the European Molecular Biology Organization
- Cancer patients remain at higher risk of severe COVID-19 disease despite third dose booster vaccine
- Comparing polygenic risk scores for risk prediction in individuals
- Measured weight loss associates with an increased risk of a cancer diagnosis
- Tool to detect cancer stem cell make-up in intestinal tumours
- First patient diagnosed earlier using liquid biopsy technology as part of the AI-REAL programme in sub-Saharan Africa
- Genetic mapping of tumours reveals how cancers grow
- DPhil in Cancer Science: A medical student's perspective
- CRUK funding to investigate the molecular drivers of stomach cancer
- Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects
- Unique Clinical Imaging Dataset Released for Artificial Intelligence Research to Accelerate Diagnosis of Prostate Cancer
- Cancer at Oxford
- Funding to research metformin’s ability to delay or prevent cancers driven by the mutated TP53 gene
- DPhil in Cancer Science: A statistician's perspective
- Introducing minimum tumour-free margins in breast cancer surgery may reduce recurrence and improve survival
- Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology
- Oxford’s KJ Patel appointed Cancer Research UK Chief Scientist
- Funding boost for Oxford’s cancer research in the NIHR Oxford BRC
- Dr Lennard Lee recognised as one of the world's 21 outstanding young physicians below the age of 40
- Profiling the entire cancer genome identifies new subgroups of blood cancer that can be used to predict likely clinical outcomes
- Pancreatic cancer could be diagnosed up to three years earlier
- Assessing a combined approach for risk-stratified population screening for colorectal cancer
- Tackling under-representation of Black data scientists in cancer research
- Dr Brian Nicholson reacts to news that GPs in England will have direct access to book cancer tests for their patients
- Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments
- Nuffield Department of Medicine receives funding to improve bowel cancer treatment
- The Nuffield Department of Medicine announces new research partnership with the University of Navarra
- Public talk: Using blood tests to detect cancer
- Research confirms important differences in colorectal cancer patients with a history of Inflammatory Bowel Disease
- Jan Bornschein receives MRC Clinical Academic Research Partnership (CARP) Award
- Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
- Cancer Science DPhil student named Oxford Sparks Ambassador
- Improving the sensitivity of therapeutic receptors for cancer therapy
- Registration now open for the Cancer Research UK Oxford Annual Symposium
- Oxford Spinouts annouce merger to tackle treatment of cold tumours
- Major funding for Oxford will help find new cancer treatments
- UNIQ+ Research Internships now open for 2023 applications
- Communication at the crossroads of the immune system
- NCRI appoints Professor Tim Maughan as new interim CEO
- International Day of Women and Girls in Science 2023
- New research opens new strategies for cancer therapeutics
- Inequalities in COVID-19 vaccine uptake remain among people with blood cancers
- Prostate cancer AI diagnosis tool begins evaluation in Oxford
- Key exosome subtype in cancer progression identified
- Study shows delaying treatment for localised prostate cancer does not increase mortality risk
- Mark Hill becomes Fellow of the Institute of Physics and Engineering in Medicine
- Any type of hormonal contraceptive may increase risk of breast cancer
- New work unpicks key cancer development pathway
- Patient and Public Involvement profile: In conversation with Sally Jeans
- New tool uses health records to predict risk of developing lung cancer within the next 10 years
- Edward O'Neill wins Prostate Cancer UK Career Acceleration Fellowship
- Four Oxford researchers awarded €2.5 million European Research Council Advanced Grants
- The Howat Foundation to fund Chair in Clinical Oncology
- Monica Olcina receives Academy of Medical Sciences Springboard Award
- Eight Oxford researchers become Fellows of the Academy of Medical Sciences
- Royal Society elects eight Oxford scientists as new Fellows
- Project submissions for the DPhil in Cancer Science now open!
- Oxford DeLIVER research attracts 1000 patients for innovative Pearl clinical study
- Multi-cancer blood test shows real promise in NHS trial
- Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma
- Patient and Public Involvement profile: In conversation with Hazel Beaver
- Hypertension drugs could improve cancer immunotherapy efficacy
- Women diagnosed with early breast cancer today are much less likely to die from the disease than 20 years ago
- Researchers discover how cancer cells adapt under acidity
- Professor David Hunter appointed as a Companion of the Order of Australia
- Oxford Cancer Immuno-Oncology Network Launched
- Tumour monocyte content can predict immunochemotherapy outcomes, study shows
- New study to investigate breast cancer in ethnic minority groups
- Children’s Cancer and Leukaemia Group Funding for Anindita Roy
- Oxford to launch UK’s first trials unit dedicated to conducting precision prevention and early detection studies
- Population-scale digital capabilities can protect cancer patients at risk of COVID
- NIHR to fund new Policy Research Unit on Cancer Research
- New tool to predict people’s risks of getting oesophageal cancer
- Ludwig Oxford’s Richard White receives 2023 Outstanding Research award from the Society for Melanoma Research
- Identification of a molecular signature that correlates with patient prognosis in SETD2-mutated cancers
- Double funding success to improve detection and risk classification of myeloproliferative neoplasms (MPNs)
- Save the date for the 2024 Oxford Cancer Symposium!
- New Study Offers Hope in Early Detection of Breast Cancer
- What matters most to people with primary liver cancer?
- Congratulations to Cancer Science DPhil Student, Giampiero Valenzano: voted lead scientist of ‘I’m a Scientist’s’ Cancer Zone
- MILI trial: the start of precision cancer prevention
- Disentangling a long-standing link between inflammation and cancer progression
- OxCODE travel awards 2023
- New target identified for pancreatic cancer treatment
- Collaboration announced to develop the use of AI to evaluate Barrett’s oesophagus
- Event: Oxford Cancer and the Kennedy Trust for Rheumatology joint Open Day for medical students.
- Professor Eileen Parkes appointed to lead Oxford’s Experimental Cancer Medicine Centre
- NDORMS launches new translational unit to further critical research into multiple myeloma
- Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa.
- Robert Watson Awarded ACP McElwain and Presidents Prize
- Deadline extended! CRUK Oxford Development Fund
- OxCODE researchers at the Early Detection of Cancer Conference 2023
- Patient Priorities in Cancer Research - What matters most to patients with MDS & MPN?
- Professor Pawel Swietach publishes new research on tumour acidosis
- New discovery furthers our understanding of how critical immune cells are controlled during an infection
- What Matters Most to people with colorectal cancer? Oxford Cancer to host workshop on patient priorities.
- DPhil in Cancer Science Programme - apply now for October 2024 entry
- University of Oxford Awarded £3 Million to Establish HealthTech Research Centre
- Cancer study seeks help from ethnic minority women
- Oxford Cancer hosts its first Spatial Biology Symposium
- Researchers characterise the landscape of somatic mutations among acid-base transporters in human cancers
- Festive Science Image Competition Winners
- Oxford University Hospitals launches new mRNA cancer vaccine trial for patients with head and neck cancers
- Oxford Cancer Precision Prevention Symposium – a recap
- Oxford Centre for Early Cancer Detection Symposium 2023 – a recap
- OCION Funding Scheme: In conversation with Kim Midwood
- First patient recruited to MILI trial
- Study assesses long-term risk of invasive breast cancer after pre-invasive disease
- Challenges for colorectal cancer risk stratification in people with IBD using histology
- World Cancer Day: Oxford University professors on the record with their contribution to the fight against cancer
- AI-based method provides insights for predicting colorectal cancer outcomes
- Crowd-sourcing approach assesses current methods for improved automated detection and boundary mapping of colorectal cancer precursors
- New study provides framework for optimising the design of antibody therapeutics
- CRUK funding success for Audrey Gérard
- OCION Funding Scheme: In conversation with Alistair Easton
- AI reveals prostate cancer is not just one disease
- Patient and Public Involvement and Engagement: Working together to improve Cancer Care by Sue Duncombe
- Funding to compare imaging modalities for liver cancer detection
- Ultrasensitive detection of p53 cancer biomarker
- Research team receives $25m Cancer Grand Challenges award
- £1.7 million for vaccine to prevent lung cancer
- OCION: In conversation with Tim Elliott
- £9m to Oxford for the Next Generation of Cancer Experts
- University of Oxford Lung cancer trial reaches 400 participants
- New study reveals how T cells gain and maintain tolerance to gut bacteria
- Researchers uncover link between DNA methylation and inflammation
- Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
- OCION Funding Scheme: In conversation with David Church and Luciana Gneo
- Blood proteins may be able to predict risk of cancer more than seven years before it is diagnosed
- Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer
- Oxford Cancer Professor Yang Shi honoured by the Royal Society
- Oxford Cancer researchers elected as Fellows of the Academy of Medical Sciences
- Oxford Cancer: 5 minutes with Professor Dame Molly Stevens
- Launch of the Oxford Translational Data Platform
- OCION 2024 Funding Scheme is live!
- Prof Anindita Roy awarded CRUK funding to study infant acute lymphoblastic leukaemia
- Oxford Cancer Immuno-Oncology Network 2024 Symposium
- Glowing dye helps surgeons eradicate prostate cancer
- Oxford Cancer to host information evening for people affected by liver cancer
- Immunotherapy: finding hidden ways to treat cancer
- OCION: In conversation with Dave Withers
- Professor Freddie Hamdy recognised in the King's Birthday Honours 2024
- GambitBio: empowering early detection at home
- Oxford success in the 2024 Lasker Essay Contest
- OCION: In conversation with Felipe Galvez-Cancino
- Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies
- The great escape artist – how tracking co-evolution could improve immunotherapy
- Oxford hosts industry event on cancer precision prevention trials
- OxCODE researchers at the inaugural Cancer Prevention Research conference 2024
- Three hospital trusts participating in an Oxford-led study evaluating AI software for diagnosing prostate cancer in clinical settings
- Identifying early symptoms associated with a diagnosis of childhood, adolescent and young adult cancers
- UK’s most ambitious melanoma research study created for patients, by patients
- Ground-breaking study reveals previously unknown genetic causes of colorectal cancer
- CRUK funding will help develop new targets for ovarian cancer
- Senior Fellowship awarded to Beth Psaila
- Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
- CRUK Oxford Development Fund - now open for applications!
- OCION: In conversation with Ignacio Melero
- OxCODE travel award winner featured by Cancer Research UK
- CRUK funding success to take LynchVax from an OCION Pump Prime award towards a clinical trial
- Oxford and NTU Singapore Study discovers new process for cells to repair DNA damage
- Research in Focus for Childhood Cancer Awareness Month
- Researchers develop new tool to better predict AML outcomes in older patients
- New study available on the Translational Data Platform
- Pseudouridine landscape across the human transcriptome mapped
- Funding to create world's first ovarian cancer prevention vaccine
- OCION: In conversation with Alfred Zippelius
- Dr Bo Sun awarded Future Leaders Grant
- UK cancer registry data is as accurate and timely as on-site trial data, new study shows
- 'Oxford LIVer cancer centre of Excellence' Launched
- New biomarker and therapeutic target identified for blood cancers
- Oxford WntUK meeting 2025
- COMBATcancer at the HIPP Summer School 2024
- OxCODE researchers at the Early Detection of Cancer Conference 2024
- Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
- 2024 OCION Pump Prime Awardees Named
- University of Oxford unveils new vaccine development partnership
- MyMelanoma study selected to join NHS DigiTrials initiative
- OCION: In conversation with Adán Pinto-Fernández
- Register for the 2025 Oxford Cancer Symposium!
- Predicting Response to Rectal Cancer Treatment through the S:CORT consortium
- Alethiomics – using Artemis to hunt down blood cancers
- OCION: In conversation with Audrey Gerard
- Oxford researchers develop blood test to enable early detection of multiple cancers
- Researchers provide a perspective on mapping the bone marrow using new spatial transcriptomic technologies
- Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research
- Early-Career Researchers Awarded Competitive Funding for Pioneering Cancer Studies
- Bowel cancer prediction test for IBD patients 90% accurate
- World Cancer Day 2025: United By Unique
- Pancreatic cancer immune map provides clues for precision treatment targeting
- OCION: In conversation with Tamsin Cargill
- Oxford Cancer Hosts Inaugural Oesophagogastric Cancer Centre of Excellence Symposium
- Lifestyle and environmental factors affect health and ageing more than our genes
- Dr Parinaz Mehdipour awarded CRUK Early Detection and Diagnosis Primer Award
- Dr David Church awarded Senior Cancer Research Fellowship from Cancer Research UK